Our results, which extend previous results of others (Chakravarti et al, 2002; Sasaki et al, 2002; Jiao et al, 2004) that examined Survivin expression in human gliomas, are intended to shed light on our understanding of the developmental genetic mechanisms of primary and secondary GBMs. Here, BIRC5 is linked to central nervous system cancer.